Vice President, Research, Infectious Diseases, MedImmune
JoAnn Suzich, Ph.D. serves as vice president, research, infectious disease at MedImmune. In this role, she is responsible for overseeing MedImmune’s research in the development of antibodies and antibody-like molecules for the prophylaxis and treatment of infectious disease. Since joining MedImmune in 1988 as a scientist, she has held several positions of increasing responsibility, most recently as senior director, infectious disease research. She has been involved in many key development programs, including Synagis® (palivizumab) and the virus-like particle technology that is the basis of the new human papillomavirus (HPV) vaccines used to prevent cervical cancer.
Before joining MedImmune, Dr. Suzich was a scientist at Molecular Genetics, Inc. from 1986 to 1988. In this position, she used cell-free transcription and translation, and recombinant vaccinia viruses, to study the expression strategy and coding capacity of the M segment RNA of Rift Valley fever virus.
Dr. Suzich holds a Bachelor of Arts degree in biology from Susquehanna University, where she graduated magna cum laude. She received her doctorate in biochemistry from Purdue University.